# Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

> **NCT03390530** · PHASE3 · WITHDRAWN · sponsor: **Albert Einstein College of Medicine**

## Conditions studied

- Intraventricular Hemorrhage of Prematurity

## Interventions

- **DRUG:** Thyroxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03390530
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-18
- **Primary completion:** 2025-12-18
- **Final completion:** 2027-01-18
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Closed by PI prior to approval
- **Last updated:** 2022-07-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03390530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03390530, "Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03390530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*